Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-12-11Clinical Trial Update: Erlotinib as First-line Treatment of Advanced Non-small Cell Lung Cancer (NSCLC) for Patients Unfit for Chemotherapy [Phase 2]
A Phase 2 study evaluating erlotinib as first-line therapy for advanced non-small cell lung cancer in patients unfit for chemotherapy has be…
-
CLINICAL_TRIALS trial_result · 2014-12-09Clinical Trial Update: Phase II Randomized Study on Locally Advanced NSCLC Escalated Dose on Individual Basis Treatment With Radiochemotherapy [Phase 2]
A Phase II randomized study evaluating escalated, individualized radiochemotherapy for locally advanced non-small cell lung cancer has been …
-
CLINICAL_TRIALS trial_result · 2014-12-09Clinical Trial Update: Stereotactic Precision And Conventional Radiotherapy Evaluation [NA]
Update notes a clinical trial comparing stereotactic precision radiotherapy with conventional radiotherapy for non-small cell lung cancer, b…
-
CLINICAL_TRIALS trial_result · 2014-12-08Clinical Trial Update: Bevacizumab in Combination With Chemotherapy in Patients With Advanced or Recurrent Non-squamous NSCLC
Clinical trial update reporting completion of a study evaluating bevacizumab in combination with chemotherapy for advanced or recurrent non-…
-
CLINICAL_TRIALS trial_result · 2014-12-08Clinical Trial Update: Bortezomib, Paclitaxel, Carboplatin and Radiation Therapy for Non-Small Cell Lung Cancer [Phase 1, Phase 2]
Phase 1/2 trial evaluating the combination of bortezomib, paclitaxel, carboplatin, and radiation therapy for non-small cell lung cancer has …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-12-08Clinical Trial Update: Phase IV Study of Tarceva in Patients With Advanced Stage IIIB/ IV Non-small Cell Lung Cancer (NSCLC)
A Phase IV study evaluating erlotinib (Tarceva) in patients with advanced non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2014-12-04Clinical Trial Update: Safety and Efficacy Study of a New Chemotherapy Agent to Treat Non-small-cell Lung Cancer [Phase 2]
Phase 2 trial sponsored by Bayer evaluating a new chemotherapy agent for non-small cell lung cancer has completed and reports safety and eff…
-
CLINICAL_TRIALS trial_result · 2014-12-04Clinical Trial Update: BIBF 1120 + Docetaxel (Japan) in Patients With Advanced Non-small-cell Lung Cancer, Phase I [Phase 1]
Phase I study in Japan evaluating the combination of BIBF 1120 (nintedanib) with docetaxel in patients with advanced non-small-cell lung can…
-
CLINICAL_TRIALS trial_result · 2014-12-04Clinical Trial Update: First-Line Chemotherapy and Panitumumab in Advanced Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 trial evaluating first-line chemotherapy with panitumumab in advanced non-small cell lung cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2014-12-03Clinical Trial Update: Cisplatin, Vinorelbine, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery [Phase 3]
This document reports the completion/update of a Phase 3 trial evaluating cisplatin, vinorelbine, and radiation therapy for patients with un…
-
CLINICAL_TRIALS trial_result · 2014-12-03Clinical Trial Update: Erlotinib in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer [Phase 3]
A Clinical Trial Update describing a Phase 3 evaluation of erlotinib for stage III or stage IV non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2014-12-02Clinical Trial Update: Phase II Study of Gefitinib Plus Nimotuzumab Versus Gefitinib in Non-small Cell Lung Cancer [Phase 2]
This document reports a completed Phase II trial comparing Gefitinib plus Nimotuzumab versus Gefitinib alone in patients with Non-Small Cell…
-
CLINICAL_TRIALS trial_result · 2014-12-01Clinical Trial Update: LUME-Lung 1: BIBF 1120 Plus Docetaxel as Compared to Placebo Plus Docetaxel in 2nd Line Non Small Cell Lung Cancer [Phase 3]
A Phase 3 trial (LUME-Lung 1) evaluating BIBF 1120 (nintedanib) plus docetaxel vs placebo plus docetaxel in second-line non-small cell lung …
-
CLINICAL_TRIALS trial_result · 2014-11-25Clinical Trial Update: Customized Neoadjuvant Versus Standard Chemotherapy in NSCL Patients With Resectable Stage IIIA (N2)Disease [Phase 2]
A Phase 2 clinical trial comparing customized neoadjuvant chemotherapy versus standard chemotherapy in patients with resectable stage IIIA (…
-
CLINICAL_TRIALS trial_result · 2014-11-24Clinical Trial Update: Study of Everolimus, Pemetrexed, Carboplatin, and Bevacizumab to Treat Stage IV Lung Cancer [Phase 1]
Phase 1 study evaluating a four-drug combination of everolimus, pemetrexed, carboplatin, and bevacizumab for stage IV non-small cell lung ca…
-
CLINICAL_TRIALS trial_result · 2014-11-21Clinical Trial Update: LUX-Lung 8: A Phase III Trial of Afatinib (BIBW 2992) Versus Erlotinib for the Treatment of Squamous Cell Lung Cancer After at Least One Prior Platinum Based Chemotherapy [Phase 3]
Phase III trial comparing afatinib versus erlotinib in squamous cell non-small cell lung cancer after platinum-based therapy; results comple…
-
CLINICAL_TRIALS trial_result · 2014-11-21Clinical Trial Update: Amifostine in Treating Patients With Stage II or Stage III Non-small Cell Lung Cancer [Phase 3]
This clinical trial update reports the completion of a Phase 3 study evaluating amifostine in patients with Stage II/III non-small cell lung…
-
CLINICAL_TRIALS trial_result · 2014-11-21Clinical Trial Update: Clinicopathological Features of NSCLC Patients Associated With the Chromosome 2p (EML4-ALK)
Completed clinical trial investigating clinicopathological features of non-small cell lung cancer patients associated with the EML4-ALK chro…
-
CLINICAL_TRIALS trial_result · 2014-11-20Clinical Trial Update: Lume Lung 2 : BIBF 1120 Plus Pemetrexed Compared to Placebo Plus Pemetrexed in 2nd Line Nonsquamous NSCLC [Phase 3]
Phase 3 LUME-Lung 2 trial comparing nintedanib (BIBF-1120) plus pemetrexed versus placebo plus pemetrexed in second-line non-squamous non-sm…
-
CLINICAL_TRIALS trial_result · 2014-11-20Clinical Trial Update: BIBF 1120 in Combination With Pemetrexed in Advanced Non Small Cell Lung Cancer (NSCLC) [Phase 1]
Phase 1 trial of BIBF 1120 (nintedanib) in combination with pemetrexed for advanced non-small cell lung cancer was terminated; results were …
-
CLINICAL_TRIALS trial_result · 2014-11-19Clinical Trial Update: A Study of Avastin (Bevacizumab) in Patients With Non-Squamous Non-Small Cell Lung Cancer With Asymptomatic Untreated Brain Metastasis [Phase 2]
Phase 2 study evaluating Avastin (bevacizumab) in patients with non-squamous non-small cell lung cancer and asymptomatic untreated brain met…
-
CLINICAL_TRIALS trial_result · 2014-11-13Clinical Trial Update: Phase 1b/2 Study of Retaspimycin HCl (IPI-504) in Combination With Everolimus in KRAS Mutant Non-small Cell Lung Cancer [Phase 1, Phase 2]
A completed Phase 1b/2 study evaluating the combination of retaspimycin HCl (IPI-504) and everolimus in KRAS-mutant non-small cell lung canc…
-
CLINICAL_TRIALS trial_result · 2014-11-11Clinical Trial Update: A Study of Tarceva (Erlotinib) in Combination With Avastin (Bevacizumab) in Patients With Advanced Non-Small Cell Lung Cancer. [Phase 2]
This is a Phase 2 trial evaluating Tarceva (erlotinib) in combination with Avastin (bevacizumab) for advanced non-small cell lung cancer; re…
-
CLINICAL_TRIALS trial_result · 2014-11-11Clinical Trial Update: Cyclophosphamide or Denileukin Diftitox Followed By Expanding a Patient's Own T Cells in the Laboratory in Treating Patients With HER-2/Neu Overexpressing Metastatic Breast Cancer, Ovarian Cancer, or Non-Small Cell Lung Cancer Previously Treated With HER-2/Neu Vaccine [Phase 1]
Phase 1 study evaluating conditioning with cyclophosphamide or denileukin diftitox followed by expansion of the patient’s own T cells for HE…
-
CLINICAL_TRIALS trial_result · 2014-11-10Clinical Trial Update: Second Line Erlotinib (Tarceva) Plus Digoxin in Non-Small Cell Lung Cancer [Phase 2]
This document reports results from a Phase 2 trial of second-line erlotinib plus digoxin in non-small cell lung cancer. The study was termin…